{"id":"anticoagulation-treatment","safety":{"commonSideEffects":[{"rate":"null","effect":"Major bleeding"},{"rate":"null","effect":"Gastrointestinal bleeding"},{"rate":"null","effect":"Hemorrhage"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through the inhibition of vitamin K-dependent clotting factors, which are essential for the coagulation cascade. The exact mechanism involves the inhibition of factors II, VII, IX, and X.","oneSentence":"Anticoagulation via inhibition of vitamin K-dependent clotting factors","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:56:48.757Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation"},{"name":"Treatment of deep vein thrombosis and pulmonary embolism"}]},"trialDetails":[{"nctId":"NCT04216394","phase":"","title":"Anticoagulation in Emergency General Surgery","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2019-10-31","conditions":"Emergency General Surgery","enrollment":4},{"nctId":"NCT07499037","phase":"PHASE2","title":"Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2027-01","conditions":"Pneumonia, Heart Failure","enrollment":200},{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT04790370","phase":"PHASE4","title":"Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2021-08-02","conditions":"Pulmonary Embolism","enrollment":544},{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT07492901","phase":"NA","title":"Impact of Ligament of Marshall Resection on Atrial Fibrillation Occurrence in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-11","conditions":"Post Operative Arrythmia","enrollment":220},{"nctId":"NCT05758077","phase":"NA","title":"Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury","status":"RECRUITING","sponsor":"SeaStar Medical","startDate":"2023-04-17","conditions":"Acute Kidney Injury","enrollment":339},{"nctId":"NCT07262255","phase":"NA","title":"WATCHMAN FLX Pro European Registry","status":"RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2025-12-17","conditions":"Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure","enrollment":1000},{"nctId":"NCT06177704","phase":"","title":"Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study","status":"NOT_YET_RECRUITING","sponsor":"Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","startDate":"2026-12-01","conditions":"Percutaneous Left Atrial Appendage Occlusion (LAAO), Device-related Thrombus (DRT), Thromboembolic Event","enrollment":100},{"nctId":"NCT07350499","phase":"","title":"Aspiration Thrombectomy Using the Symphony or Prodigy System","status":"RECRUITING","sponsor":"Imperative Care, Inc.","startDate":"2026-02-13","conditions":"Arterial Thromboembolism, Venous Thromboembolism, Pulmonary Embolism","enrollment":750},{"nctId":"NCT06753786","phase":"NA","title":"Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2024-10-21","conditions":"Venous Thromboembolism, Pulmonary Embolism, Intracerebral Hemorrhage","enrollment":200},{"nctId":"NCT07486739","phase":"NA","title":"Functional And STructural Assesment of the Heart by Artificial Intelligence-enabled Electrocardiogram for the Management of Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2026-05","conditions":"Atrial Fibrillation (AF)","enrollment":1724},{"nctId":"NCT07479147","phase":"","title":"SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation","status":"RECRUITING","sponsor":"Taichung Veterans General Hospital","startDate":"2025-12-16","conditions":"Ischemic Stroke, Embolic Stroke of Undetermined Source, Patent Foramen Ovale (PFO)","enrollment":400},{"nctId":"NCT07487532","phase":"NA","title":"Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-04-01","conditions":"Atrial Fibrillation (AF)","enrollment":120},{"nctId":"NCT06650501","phase":"PHASE4","title":"Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2026-01-15","conditions":"Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia","enrollment":300},{"nctId":"NCT04956978","phase":"NA","title":"Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-06-01","conditions":"Atrial Fibrillation","enrollment":40},{"nctId":"NCT02928497","phase":"NA","title":"Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2017-02-06","conditions":"Stroke","enrollment":481},{"nctId":"NCT04701749","phase":"","title":"Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2021-02-24","conditions":"Radiation Cystitis, Non-valvular Atrial Fibrillation","enrollment":40},{"nctId":"NCT07175428","phase":"PHASE2","title":"Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2025-10-20","conditions":"Atrial Fibrillation (AF)","enrollment":1200},{"nctId":"NCT04996667","phase":"PHASE2","title":"Effect of iNO in Patients With Submassive and Massive PE","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2026-06-01","conditions":"Pulmonary Embolism, Pulmonary Embolism Subacute Massive","enrollment":""},{"nctId":"NCT04907825","phase":"PHASE4","title":"A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2023-03-13","conditions":"Atrial Fibrillation, Stroke","enrollment":14},{"nctId":"NCT05300139","phase":"","title":"Ancillary Study of the ULTREC Project","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2021-11-29","conditions":"Deep Vein Thrombosis","enrollment":18},{"nctId":"NCT04077463","phase":"PHASE1","title":"A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-09-04","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":701},{"nctId":"NCT05900388","phase":"","title":"A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)","status":"NOT_YET_RECRUITING","sponsor":"Bayer","startDate":"2026-09-01","conditions":"Venous Thromboembolism, Children Under 2 Years","enrollment":850},{"nctId":"NCT07477977","phase":"NA","title":"Dose for Reversal of Heparin After Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03-01","conditions":"Open Heart Surgery","enrollment":195},{"nctId":"NCT07467889","phase":"","title":"Impact of CRRT on Serum Carnitine and Micronutrient Levels","status":"COMPLETED","sponsor":"Gulhane Training and Research Hospital","startDate":"2023-01-01","conditions":"Acute Kidney Injury (Nontraumatic), Critical Illness","enrollment":43},{"nctId":"NCT07456085","phase":"PHASE3","title":"Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves","status":"ENROLLING_BY_INVITATION","sponsor":"Rawalpindi Institute of Cardiology","startDate":"2025-11-13","conditions":"Valvular Heart Disease Patients","enrollment":60},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT06883864","phase":"NA","title":"Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-04-08","conditions":"Atrial Fibrillation (AF), Catheter Ablation, Atrial Functional Mitral Regurgitation","enrollment":146},{"nctId":"NCT07469072","phase":"PHASE2","title":"Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-02-25","conditions":"Continuous Renal Replacement Therapy (CRRT)","enrollment":92},{"nctId":"NCT04618913","phase":"","title":"Anticoagulation in Patients With Venous Thromboembolism and Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2020-12-14","conditions":"Neoplasms, Embolism","enrollment":1},{"nctId":"NCT05038228","phase":"","title":"High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2022-08-01","conditions":"Atrial Fibrillation","enrollment":1},{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT06588634","phase":"NA","title":"The PERSEVERE Study","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2024-12-16","conditions":"Pulmonary Embolism, Pulmonary Thromboembolism","enrollment":200},{"nctId":"NCT06863155","phase":"","title":"Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation","status":"RECRUITING","sponsor":"Fundación EPIC","startDate":"2025-05-06","conditions":"Coronary Artery Disease, Ischemic Heart Disease","enrollment":500},{"nctId":"NCT07458672","phase":"NA","title":"TAVR for Aortic Regurgitation Under TTE Guidance","status":"NOT_YET_RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2026-03-10","conditions":"Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR)","enrollment":30},{"nctId":"NCT06901466","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-06-13","conditions":"Mitral Regurgitation","enrollment":880},{"nctId":"NCT03297281","phase":"NA","title":"Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)","status":"RECRUITING","sponsor":"Clinique Pasteur","startDate":"2017-10-30","conditions":"Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction","enrollment":389},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT06871228","phase":"NA","title":"Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-08-05","conditions":"Atrial Fibrillation (AF)","enrollment":4100},{"nctId":"NCT06055920","phase":"NA","title":"The PEERLESS II Study","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2023-11-17","conditions":"Pulmonary Embolism","enrollment":1200},{"nctId":"NCT07436702","phase":"","title":"Optimal Time for Reperfusion in Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Azienda ULSS 8 Berica","startDate":"2025-11-25","conditions":"Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute","enrollment":500},{"nctId":"NCT07441759","phase":"","title":"throMboembolic Risk Associated To High atrIal Fibrillation riSk","status":"NOT_YET_RECRUITING","sponsor":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","startDate":"2026-07-06","conditions":"MACE, Atrial Fibrillation (AF), Quality-adjusted Life-years","enrollment":1000},{"nctId":"NCT07441382","phase":"NA","title":"Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-01","conditions":"Atrial Fibrillation (AF), Stroke, Hemorrhage","enrollment":200},{"nctId":"NCT03041805","phase":"","title":"Caprini Score in Venous Surgery: a Prospective Cohort Study","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2017-01-01","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":3000},{"nctId":"NCT06526546","phase":"","title":"ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2024-10-31","conditions":"Paroxysmal Atrial Fibrillation","enrollment":364},{"nctId":"NCT07439731","phase":"","title":"Research on Post-Stroke Anticoagulation Strategies for Atrial Fibrillation Based on Left Atrial Appendage Flow Velocity Measured by Intracardiac Echocardiography (ICE)","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2024-01-01","conditions":"Atrial Fibrillation (AF)","enrollment":172},{"nctId":"NCT07246005","phase":"PHASE2","title":"LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus","status":"NOT_YET_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2026-12-01","conditions":"Left Ventricular Thrombus","enrollment":120},{"nctId":"NCT07438054","phase":"","title":"PRO-AF 52: Monthly Primary-Care 12-Lead ECG Screening for Incident Atrial Fibrillation in Adults Aged ≥65 Years","status":"ENROLLING_BY_INVITATION","sponsor":"Kotyora Family Medicine Health Management and Education Association","startDate":"2026-01-01","conditions":"Atrial Fibrillation (AF)","enrollment":1000},{"nctId":"NCT07434661","phase":"PHASE3","title":"Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR","status":"NOT_YET_RECRUITING","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2026-02","conditions":"Valve Disease, Heart, Atrial Fibrillation (AF), Valve Replacement Surgery","enrollment":120},{"nctId":"NCT07432529","phase":"PHASE3","title":"Design and Rationale of the COLT Study","status":"NOT_YET_RECRUITING","sponsor":"Azienda Sanitaria Locale ASL 6, Livorno","startDate":"2026-06-01","conditions":"Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome, Venous Thromboembolism (VTE)","enrollment":940},{"nctId":"NCT07242326","phase":"","title":"SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)","status":"ENROLLING_BY_INVITATION","sponsor":"Kotyora Family Medicine Health Management and Education Association","startDate":"2025-12-15","conditions":"Medication Adherence, Atrial Fibrillation (AF), Direct Oral Anticoagulants (DOACs)","enrollment":1000},{"nctId":"NCT06355986","phase":"NA","title":"Computerized Decision Support to Prevent Stroke in Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-12-30","conditions":"Atrial Fibrillation, Stroke","enrollment":2500},{"nctId":"NCT07430956","phase":"PHASE3","title":"Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable","status":"NOT_YET_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-18","conditions":"Atrial Fibrillation (AF)","enrollment":2628},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT05976685","phase":"NA","title":"Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-05-01","conditions":"Ischemic Stroke, Atrial Fibrillation","enrollment":482},{"nctId":"NCT07422701","phase":"","title":"Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2026-02-01","conditions":"Portal Vein Thrombosis, Liver Cirrhosis","enrollment":2522},{"nctId":"NCT06087952","phase":"NA","title":"Leiden Thrombosis Recurrence Risk Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2021-06-18","conditions":"Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism","enrollment":608},{"nctId":"NCT06533345","phase":"NA","title":"VCOM Pain Free Research Collaborative","status":"RECRUITING","sponsor":"Edward Via Virginia College of Osteopathic Medicine","startDate":"2024-08-30","conditions":"Chronic Pain","enrollment":120},{"nctId":"NCT07419802","phase":"","title":"OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study","status":"RECRUITING","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2026-03-01","conditions":"Sepsis, Septic Shock, Blood Purification","enrollment":29},{"nctId":"NCT05836987","phase":"PHASE3","title":"The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-07-13","conditions":"Atrial Fibrillation","enrollment":5350},{"nctId":"NCT07326215","phase":"NA","title":"A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2025-12-11","conditions":"Acute Respiratory Distress Syndrome, Acute Kidney Injury","enrollment":99},{"nctId":"NCT05825573","phase":"PHASE3","title":"Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-05-15","conditions":"Intracardiac Thrombus, STEMI, Heart Failure","enrollment":340},{"nctId":"NCT07404345","phase":"PHASE4","title":"Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)","status":"NOT_YET_RECRUITING","sponsor":"Hospital Civil de Guadalajara","startDate":"2026-03-01","conditions":"Hemodialysis Access Failure, Kidney Disease, End-Stage, Hemodialysis Catheter","enrollment":54},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT05712200","phase":"PHASE3","title":"Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)","status":"RECRUITING","sponsor":"Anthos Therapeutics, Inc.","startDate":"2022-12-27","conditions":"Atrial Fibrillation (AF)","enrollment":1900},{"nctId":"NCT03907046","phase":"PHASE3","title":"Anticoagulation in ICH Survivors for Stroke Prevention and Recovery","status":"RECRUITING","sponsor":"Yale University","startDate":"2020-01-28","conditions":"Intracerebral Hemorrhage, Atrial Fibrillation","enrollment":700},{"nctId":"NCT07399977","phase":"NA","title":"Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2026-01-30","conditions":"Venous Thromboembolism, Deep Venous Thrombosis","enrollment":259},{"nctId":"NCT07407790","phase":"NA","title":"The Southern-Norway Post-Stroke Atrial Fibrillation Study","status":"RECRUITING","sponsor":"Sorlandet Hospital HF","startDate":"2026-01-10","conditions":"Atrial Fibrillation (AF), Atrial Fibrillation (Prevention of Stroke), Ischemic Stroke","enrollment":450},{"nctId":"NCT06396858","phase":"PHASE4","title":"Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Brazilian Clinical Research Institute","startDate":"2026-07","conditions":"Ischemic Stroke","enrollment":4500},{"nctId":"NCT07404436","phase":"PHASE4","title":"Rivaroxaban in Idiopathic Membranous Nephropathy","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-01-05","conditions":"Idiopathic Membranous Nephropathy","enrollment":134},{"nctId":"NCT06429332","phase":"PHASE4","title":"International Care Bundle Evaluation in Cerebral Hemorrhage Research","status":"RECRUITING","sponsor":"Region Skane","startDate":"2025-01-07","conditions":"Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage","enrollment":3500},{"nctId":"NCT07372716","phase":"NA","title":"Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2026-03","conditions":"Thrombosis, Cancer, Thrombosis, Deep Vein","enrollment":700},{"nctId":"NCT07139314","phase":"NA","title":"Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-09-24","conditions":"Ischemic Stroke, Atrial Fibrillation","enrollment":240},{"nctId":"NCT06196307","phase":"","title":"Early Warning and Classification Model for Acute Non-traumatic Chest Pain","status":"RECRUITING","sponsor":"Xiao-nan He","startDate":"2022-08-30","conditions":"Chest Pain","enrollment":10000},{"nctId":"NCT07005024","phase":"PHASE3","title":"DOAC - Dosing Options in AntiCoagulation Prophylaxis","status":"RECRUITING","sponsor":"University of Vermont","startDate":"2025-10-17","conditions":"Cancer, VTE (Venous Thromboembolism)","enrollment":996},{"nctId":"NCT07139301","phase":"NA","title":"Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-09-04","conditions":"Ischemic Stroke, Atrial Fibrillation","enrollment":438},{"nctId":"NCT05701917","phase":"NA","title":"DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2023-01-06","conditions":"Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome","enrollment":300},{"nctId":"NCT05848713","phase":"PHASE3","title":"AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-10","conditions":"Community-acquired Pneumonia","enrollment":4000},{"nctId":"NCT04496362","phase":"PHASE4","title":"Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor Research Institute","startDate":"2018-10-10","conditions":"ECMO, Heparin, Respiratory Failure","enrollment":100},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT06080074","phase":"PHASE2","title":"Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-04-15","conditions":"Heart Failure, Cardiogenic Shock, Congenital Heart Disease","enrollment":50},{"nctId":"NCT05156983","phase":"PHASE3","title":"A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery","status":"RECRUITING","sponsor":"Takeda","startDate":"2022-08-24","conditions":"Coagulation Disorder","enrollment":328},{"nctId":"NCT06486181","phase":"PHASE4","title":"Second Line Endovascular Treatment in Acute DVT","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT07365644","phase":"","title":"Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier le Mans","startDate":"2026-01-01","conditions":"Prophylactic Anticoagulation","enrollment":1111},{"nctId":"NCT06909240","phase":"NA","title":"Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)","status":"RECRUITING","sponsor":"Hvidovre University Hospital","startDate":"2025-11-15","conditions":"Deep Vein Thrombosis (DVT)","enrollment":152},{"nctId":"NCT07236463","phase":"PHASE1, PHASE2","title":"Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2026-02-01","conditions":"Acute Kidney Injury, Sepsis","enrollment":14},{"nctId":"NCT04113421","phase":"","title":"Quantitative 3-Dimensional Chest CT Vascular Reconstruction Before and After Anticoagulation for Pulmonary Embolism","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2019-12-01","conditions":"Pulmonary Embolism","enrollment":10},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07352358","phase":"PHASE4","title":"Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-30","conditions":"Cerebral Venous Thrombosis","enrollment":72},{"nctId":"NCT04273607","phase":"PHASE2, PHASE3","title":"Anticoagulation-free VV ECMO for Acute Respiratory Failure","status":"RECRUITING","sponsor":"Damian Ratano","startDate":"2022-09-01","conditions":"Extracorporeal Membrane Oxygenation Complication","enrollment":40},{"nctId":"NCT04268940","phase":"","title":"Thrombo-Elastography Guided Management of ECMO","status":"COMPLETED","sponsor":"Damian Ratano","startDate":"2020-06-03","conditions":"Extracorporeal Circulation of Blood; Thrombocytopenia","enrollment":61},{"nctId":"NCT07343895","phase":"NA","title":"Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tromsø Study","status":"RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2025-10-24","conditions":"Atrial Fibrillation (AF), Stroke, NT-pro-BNP","enrollment":4000},{"nctId":"NCT06440317","phase":"","title":"Immunothrombosis With Septic Shock Undergoing Renal Replacement Therapy With the OXIRIS Membrane","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2026-04","conditions":"Sepsis","enrollment":30},{"nctId":"NCT07342127","phase":"","title":"Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-02-01","conditions":"Factor V Leiden Heterozygous Mutation, Factor II Heterozygous Mutation, Pregnancy","enrollment":100},{"nctId":"NCT05565209","phase":"","title":"Left Atrial Appendage Closure Registry of Henri Mondor Hospital","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-09-24","conditions":"Atrial Fibrillation","enrollment":250},{"nctId":"NCT07335770","phase":"","title":"Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)","status":"ENROLLING_BY_INVITATION","sponsor":"Minjie Lu","startDate":"2008-01-01","conditions":"Cardiac Masses","enrollment":2000},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":"Stroke, Atrial Fibrillation","enrollment":2270},{"nctId":"NCT07330869","phase":"","title":"Warfarin Effects on Male Fertility After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Città di Lecce Hospital, GVM Care & Research","startDate":"2026-02","conditions":"Male Infertility, Heart Valve Disease","enrollment":90},{"nctId":"NCT06842147","phase":"NA","title":"Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-03-01","conditions":"Atrial Fibrillation (AF)","enrollment":15360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1712,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Anticoagulation treatment.","genericName":"Anticoagulation treatment.","companyName":"Samsung Medical Center","companyId":"samsung-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anticoagulation via inhibition of vitamin K-dependent clotting factors Used for Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, Treatment of deep vein thrombosis and pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}